• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典特定人群中原发性胆汁性肝硬化的发病率和患病率。

Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden.

作者信息

Löfgren J, Järnerot G, Danielsson D, Hemdal I

出版信息

Scand J Gastroenterol. 1985 Jun;20(5):647-50. doi: 10.3109/00365528509089711.

DOI:10.3109/00365528509089711
PMID:4023628
Abstract

The incidence and prevalence of antimitochondrial antibody-positive primary biliary cirrhosis (PBC) has been studied within a defined area in Sweden served by one hospital. During the period 1976-1983 the yearly incidence of PBC was 1.4/10(5) inhabitants, and on 31 December 1983 the prevalence was 12.8/10(5) inhabitants. The prevalence is the highest reported so far. At the time of diagnosis half of the patients were clinically asymptomatic. Two of the patients also had celiac disease with osteomalacia responding to a gluten-free diet. Gallstone disease occurred in 30% of the patients. Four patients died--two of liver-related complications, one of colonic carcinoma, and one of staphylococcal septicemia and endocarditis. One further patient, who is still alive, developed hypernephroma. Our results indicate that PBC is a fairly benign disease in most patients, with a slow progress during which they lead a fairly normal life.

摘要

在瑞典一家医院服务的特定区域内,对线粒体抗体阳性的原发性胆汁性肝硬化(PBC)的发病率和患病率进行了研究。在1976 - 1983年期间,PBC的年发病率为每10万居民中有1.4例,到1983年12月31日,患病率为每10万居民中有12.8例。这是迄今为止报告的最高患病率。在诊断时,一半的患者临床上无症状。其中两名患者还患有乳糜泻伴骨软化症,对无麸质饮食有反应。30%的患者患有胆结石病。有4名患者死亡,两名死于肝脏相关并发症,一名死于结肠癌,一名死于葡萄球菌败血症和心内膜炎。另有一名患者仍在世,患了肾上腺样瘤。我们的结果表明,PBC在大多数患者中是一种相当良性的疾病,进展缓慢,在此期间他们能过上相当正常的生活。

相似文献

1
Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden.瑞典特定人群中原发性胆汁性肝硬化的发病率和患病率。
Scand J Gastroenterol. 1985 Jun;20(5):647-50. doi: 10.3109/00365528509089711.
2
Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden.瑞典北部特定农村人口中原发性胆汁性肝硬化的流行病学
Hepatology. 1990 Mar;11(3):458-64. doi: 10.1002/hep.1840110317.
3
The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population.特定人群中原发性胆汁性肝硬化的患病率及临床谱。
Scand J Gastroenterol. 1984 Oct;19(7):971-6.
4
Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.挪威人群中原发性胆汁性肝硬化、原发性硬化性胆管炎及自身免疫性肝炎的发病率和患病率。
Scand J Gastroenterol. 1998 Jan;33(1):99-103. doi: 10.1080/00365529850166284.
5
Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study.原发性胆汁性肝硬化发病率和患病率的上升:一项基于大规模人群的研究。
Liver Int. 2014 Jul;34(6):e31-8. doi: 10.1111/liv.12434. Epub 2014 Jan 14.
6
Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community.西班牙某社区原发性胆汁性肝硬化的发病率、患病率及临床病程
Eur J Gastroenterol Hepatol. 2007 Oct;19(10):859-64. doi: 10.1097/MEG.0b013e328277594a.
7
Prevalence and incidence of primary biliary cirrhosis are increasing in Finland.芬兰原发性胆汁性肝硬化的患病率和发病率正在上升。
Scand J Gastroenterol. 2007 Nov;42(11):1347-53. doi: 10.1080/00365520701396034.
8
Primary biliary cirrhosis in Estonia. With special reference to incidence, prevalence, clinical features, and outcome.爱沙尼亚的原发性胆汁性肝硬化。特别提及发病率、患病率、临床特征及预后。
Scand J Gastroenterol. 1995 Apr;30(4):367-71. doi: 10.3109/00365529509093292.
9
The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences.原发性胆汁性肝硬化与乳糜泻之间的关联:相对患病率研究
Gut. 1998 Jan;42(1):120-2. doi: 10.1136/gut.42.1.120.
10
Clinical profile of primary biliary cirrhosis that was diagnosed as symptomatic primary biliary cirrhosis according to the revised diagnostic criteria in Japan.根据日本修订的诊断标准被诊断为症状性原发性胆汁性肝硬化的原发性胆汁性肝硬化的临床特征。
Intern Med. 2010;49(12):1073-8. doi: 10.2169/internalmedicine.49.3169. Epub 2010 Jun 15.

引用本文的文献

1
Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort.原发性胆汁性胆管炎在全国性瑞典基于人群队列中的发病率、患病率和结局。
Sci Rep. 2019 Aug 8;9(1):11525. doi: 10.1038/s41598-019-47890-2.
2
Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.临床医生是否准备好安全使用分层治疗原发性胆汁性胆管炎(PBC)?一项教育意识研究。
Dig Dis Sci. 2018 Oct;63(10):2547-2554. doi: 10.1007/s10620-018-5074-8. Epub 2018 May 8.
3
Primary biliary cholangitis: a comprehensive overview.
原发性胆汁性胆管炎:全面概述。
Hepatol Int. 2017 Nov;11(6):485-499. doi: 10.1007/s12072-017-9830-1. Epub 2017 Nov 21.
4
Incidence of Primary Biliary Cholangitis in a Rural Midwestern Population.美国中西部农村人口中原发性胆汁性胆管炎的发病率。
Clin Med Res. 2017 Jun;15(1-2):13-18. doi: 10.3121/cmr.2017.1351. Epub 2017 May 9.
5
To screen or not to screen? Celiac antibodies in liver diseases.筛查还是不筛查?肝脏疾病中的乳糜泻抗体。
World J Gastroenterol. 2017 Feb 7;23(5):776-791. doi: 10.3748/wjg.v23.i5.776.
6
Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis.原发性胆汁性胆管炎女性发病率和男性死亡率的演变趋势
Sci Rep. 2016 May 19;6:25906. doi: 10.1038/srep25906.
7
Recent advances in the development of farnesoid X receptor agonists.法尼醇 X 受体激动剂的研究进展。
Ann Transl Med. 2015 Jan;3(1):5. doi: 10.3978/j.issn.2305-5839.2014.12.06.
8
Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis.环境途径导致的自身免疫性疾病:原发性胆汁性肝硬化和多发性硬化症。
Arch Med Sci. 2011 Jun;7(3):368-80. doi: 10.5114/aoms.2011.23398. Epub 2011 Jul 11.
9
Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis.原发性胆汁性肝硬化和干燥综合征:自身免疫性上皮炎。
J Autoimmun. 2012 Aug;39(1-2):34-42. doi: 10.1016/j.jaut.2011.11.005. Epub 2011 Dec 16.
10
Liver complications in celiac disease.乳糜泻的肝脏并发症
Hepat Mon. 2011 May;11(5):333-41.